Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Belantamab mafodotin for treating relapsed or refractory multiple myeloma	Belantamab mafodotin (GSK2857916; anti-BCMA-ADC)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2022	View \| Download
Belantamab mafodotin for relapsed / refractory multiple myeloma – Fourth line	Belantamab mafodotin (GSK2857916; anti-BCMA-ADC)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2019	View \| Download
BCX7353 for prevention of acute attacks of angioedema in hereditary angioedema	BCX7353 (Berotralstat; ORLADEYO)	Hereditary angioedema (HAE)	Genetic Disorders , Immunology	2019	View \| Download
bb2121 for Relapsed and Refractory Multiple Myeloma	Idecabtagene vicleucel (Ide-cel; bb2121)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2018	View \| Download
Basal Insulin-Fc for type 2 diabetes mellitus	Basal Insulin-Fc	Type 2 diabetes	Endocrine Nutritional and Metabolic Disorders	2023	View \| Download
Basal Insulin-Fc for treating type 1 diabetes	Basal Insulin-Fc	Type 1 diabetes	Endocrine Nutritional and Metabolic Disorders	2023	View \| Download
Baricitinib for treatment of severe alopecia areata in adults	Baricitinib (LY3009104; Olumiant)	Alopecia areata	Dermatology , Immunology	2021	View \| Download
Baricitinib for treating juvenile idiopathic arthritis in paediatric patients	Baricitinib (LY3009104; Olumiant)	Juvenile psoriatic arthritis	Rheumatology	2022	View \| Download
Baricitinib for treating atopic dermatitis in children and adolescents	Baricitinib (LY3009104; Olumiant)	Atopic dermatitis	Dermatology	2022	View \| Download
Baricitinib for systemic lupus erythematosus	Baricitinib (LY3009104; Olumiant)	Systemic lupus erythematosus (SLE)	Immunology , Nephrology	2021	View \| Download